Beta
Back to CVS.US Analysis

Ticker

Value

empty

There is no following symbol in this watchlist.

  • Revenue by Segments
  • EPS
  • EPS Diluted
  • Revenue
  • Operation Income
  • Net Income
  • Operating Expenses
  • Cash Flow
  • Cash & Debt
  • Current Contract Liabilities
revenue-chart

CVS Revenue

This disclaimer is provided by TradingValley Inc. and includes any messages, news, research, analysis, prices or other information provided by the Company's website, the application "Growin App" and other services provided through the Company's website. It is only general market information for educational and investment decision-making reference, and does not constitute any investment advice. View Growin Disclaimer

The latest data point for CVS Revenue in Q4'25 shows $105.7B USD, marking a year-over-year growth of 8.2% and representing the highest quarterly figure in the observed period from Q1'23 to Q4'25. Over the timeframe from Q1'23 to Q4'25, CVS Revenue exhibits a consistent upward trend, rising from $85.3B in Q1'23 to $105.7B in Q4'25, with notable acceleration in 2025 quarters following a temporary slowdown in 2024 where growth dipped to 2.6% in Q2'24. Year-over-year growth rates fluctuated between 2.6% and 11.9%, averaging around 7.5%, with the bar chart highlighting steady quarterly increases and the line overlay underscoring improving momentum in the latter half of the period. This pattern suggests robust expansion, potentially driven by operational efficiencies or market demand in the healthcare sector.